Hoenigl, Martin, Seidel, Danila, Carvalho, Agostinho ORCID: 0000-0001-8935-8030, Rudramurthy, Shivaprakash M., Arastehfar, Amir ORCID: 0000-0002-4361-4841, Gangneux, Jean-Pierre ORCID: 0000-0002-4974-5607, Nasir, Nosheen, Bonifaz, Alexandro, Araiza, Javier, Klimko, Nikolai, Serris, Alexandra, Lagrou, Katrien, Meis, Jacques F., Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Perfect, John R., White, P. Lewis and Chakrabarti, Arunaloke (2022). The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe, 3 (7). S. E543 - 10. AMSTERDAM: ELSEVIER. ISSN 2666-5247

Full text not available from this repository.

Abstract

Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS-CoV2, which might favour secondary infections. In this Review, we analysed 80 published and unpublished cases of COVID-19-associated mucormycosis. Uncontrolled diabetes, as well as systemic corticosteroid treatment, were present in most patients with COVID-19-associated mucormycosis, and rhino-orbital cerebral mucormycosis was the most frequent disease. Mortality was high at 49%, which was particularly due to patients with pulmonary or disseminated mucormycosis or cerebral involvement. Furthermore, a substantial proportion of patients who survived had life-changing morbidities (eg, loss of vision in 46% of survivors). Our Review indicates that COVID-19-associated mucormycosis is associated with high morbidity and mortality. Diagnosis of pulmonary mucormycosis is particularly challenging, and might be frequently missed in India.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Hoenigl, MartinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Seidel, DanilaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Carvalho, AgostinhoUNSPECIFIEDorcid.org/0000-0001-8935-8030UNSPECIFIED
Rudramurthy, Shivaprakash M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Arastehfar, AmirUNSPECIFIEDorcid.org/0000-0002-4361-4841UNSPECIFIED
Gangneux, Jean-PierreUNSPECIFIEDorcid.org/0000-0002-4974-5607UNSPECIFIED
Nasir, NosheenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bonifaz, AlexandroUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Araiza, JavierUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Klimko, NikolaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Serris, AlexandraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lagrou, KatrienUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Meis, Jacques F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cornely, Oliver A.UNSPECIFIEDorcid.org/0000-0001-9599-3137UNSPECIFIED
Perfect, John R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
White, P. LewisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chakrabarti, ArunalokeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-696486
DOI: 10.1016/S2666-5247(21)00237-8
Journal or Publication Title: Lancet Microbe
Volume: 3
Number: 7
Page Range: S. E543 - 10
Date: 2022
Publisher: ELSEVIER
Place of Publication: AMSTERDAM
ISSN: 2666-5247
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
INVASIVE MOLD INFECTIONS; EPIDEMIOLOGY; PATIENTMultiple languages
Infectious Diseases; MicrobiologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69648

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item